Background: Oxidative stress is involved in lead toxicity. This suggests that some antioxidants may play a role in the treatment of lead poisoning. In the light of this, the aim of the study was to determine whether β-carotene administration reduces oxidative stress and homocysteine level in workers chronically exposed to lead. Material and Methods: The exposed population included healthy male workers exposed to lead who were randomly divided into 2 groups (mean blood lead level ca. 44 µg/dl). Workers in the 1st group (N = 49, reference group) had no antioxidants, drugs, vitamins or dietary supplements administered, while workers in the 2nd group (N = 33) had β-carotene administered in a dose of 10 mg per day for 12 weeks. Biochemical analysis included markers of lead-exposure and the level of malondialdehyde (MDA), an oxidative stress biomarker. We also measured the level of homocysteine (Hcy) and thiol groups as well as the activity of superoxide dismutase (SOD) and its isoenzyme EC-SOD in serum. Results: After supplementation, the level of MDA significantly decreased, compared to baseline, by 16%, and to the reference group. When compared to the reference group, Hcy level was also significantly decreased. However, the level of thiol groups was significantly higher after supplementation with β-carotene compared to the reference group. Analogically, the activity of SOD and EC-SOD was significantly higher compared to the baseline and to the reference group. Conclusions: Despite some controversies over antioxidant properties of β-carotene, our results indicate that its antioxidant action could provide some beneficial effects in lead poisoning independent of chelation. Med Pr 2014;65(3):309-316
INTRODUCTION
Lead is one of the earliest metals discovered by the human race. Due to softness, high malleability, ductility, low melting point and resistance to corrosion, lead has many industrial applications. Widespread usage of lead and its accumulation in the environment make exposure to this xenobiotic unavoidable (1, 2) . In Poland, there are approximately 26 500 workers occupationally exposed to lead and only 76% of them are monitored for blood lead levels. Exposure of approximately 2000 persons exceeds the Polish MAC level of 0.050 mg/m 3 . Therefore, it is possible to state that occupational exposure to lead is still a vital problem in Polish industry (3) .
A safe level of exposure to lead has not been defined. Data indicates that even low exposure to lead may induce cognitive dysfunction, neurobehavioral disorders, neurological damage, hypertension and renal impairment (4) . Pathogenesis of lead poisoning is multifactorial and oxidative stress has been suggested to be one possible mechanism for its toxicity. Lead generates reactive oxygen species (ROS) directly or by up-regulating activity of xanthine oxidase (XO) which generates superoxide anions (5) . In addition, lead reduces antioxidant reserves. Having high affinity for thiol groups, lead depletes the level of glutathione, which is a major thiolcontaining antioxidant of the human body, and binds to the thiol groups of many enzymes. In consequence, lead disrupts the function of antioxidant enzymes, such as superoxide dismutase or catalase. Delta-aminolevulinic acid dehydratase (delta-ALAD) is a well-known enzyme that is also inhibited by lead. This inhibition results in the accumulation of delta-aminolevulinic acid (ALAD) which additively acts as a pro-oxidant (1, 6) .
Several recent studies have reported that homocysteine (Hcy) concentration is believed to be increased in lead poisoning as well. Homocysteine level exceeding 15 μmol/l (hyperhomocysteinemia) has been shown to be associated with the development of atherosclerosis and greater risk for cardiovascular disease. Besides, hyperhomocysteinemia increases the risk of stroke, peripheral vascular disease and cognitive impairment (7, 8) .
Chelation is the conventional recommendation for acute lead toxicity with encephalopathic damage, whereas treatment for chronic exposure to lead is still under investigation (4) . The assumption that oxidative stress is involved in lead toxicity suggests that some antioxidants may play a role in the treatment of lead poisoning. One of them is β-carotene. In the human body, β-carotene is not only a stock form of vitamin A, but also associated with intercellular communication, interferons' activation, inhibition of cells proliferation and modulation of cells differentiating (9) . As an antioxidant, β-carotene scavenges singlet oxygen physically without degradation and reacts with free radicals, such as the peroxyl, hydroxyl and superoxide radicals. Carotenoids have been shown to be able to decrease oxidative damage to DNA, lipids and proteins (10, 11) . Some authors postulate β-carotene can reduce the incidence of many diseases, such as cancer, atherosclerosis, agerelated macular degeneration and multiple sclerosis (6) . In the light of this, the aim of the study was to determine whether β-carotene administration reduces oxidative stress and homocysteine level in workers chronically exposed to lead.
MATERIAL AND METHODS

Study population
The exposed population included healthy male volunteers employed in zinc and lead works located in Miasteczko Śląskie, Poland. Participants were recruited by a specialist of occupational medicine during prophylactic medical examinations. All of them provided informed consent to the study. Their mean age was 41±8.57. They were exposed to lead on average for 17±9.47 years. The mean concentration of lead in the air at workplaces was 0.083±0.12 mg/m 3 . Blood levels of lead (PbB) and zincprotoporphyrin (ZPP) served as exposure markers.
The inclusion criteria were the following: occupational exposure to lead (PbB > 20 µg/dl and ZPP > 2.5 µg/g Hb), no significant findings in physical examination and no past or present history of any chronic disease. Exclusion criteria included contraindications for β-carotene administration.
The examined population was randomly divided into 2 groups. Workers in the 1st group (reference group) had no any antioxidants, drugs, vitamins or dietary supplements administered, while workers in the 2nd group (CAR group) had β-carotene (Beta Karoten®, Chance) administered orally in a dose of 10 mg once a day. The study lasted 12 weeks. At the end of the study, participants were asked to return their empty pill boxes back to one of the study investigators to assess compliance with the treatment protocol.
Participants' blood was drawn two times: at the beginning of the study and after 12 weeks of supplementation. Biochemical analysis included markers of lead-exposure: PbB and ZPP levels in the blood. The level of malondialdehyde (MDA) in serum served as an β-carotene administration in lead-exposure Nr 3 311 oxidative stress biomarker. We also measured the level of Hcy and thiol groups (PSH) as well as the activity of superoxide dismutase (SOD) and its isoenzyme EC-SOD in serum served as an oxidative stress biomarker. Additively, we measured levels of copper (Cu) and zinc (Zn), the metal cofactors for EC-SOD. The experimental protocol was approved by the Bioethics Committee of the Medical University of Silesia in Katowice (decission No. NN-6501-36/I/06).
Laboratory procedures
The whole blood was drawn by venipuncture. 10 ml of blood was collected into plain tubes to obtain serum, while 15 ml was placed in tubes containing ethylenediamine-tetraacetic disodium acid (EDTA) solution as an anticoagulant. Samples were stored in freezers at -80°C for up to 3 months. PbB and ZPP levels were determined immediately after blood drawing.
PbB was analyzed in the whole blood by graphite furnace atomic absorption spectrophotometry using Unicam 929 and 939OZ Atomic Absorption Spectrometers with GF90 and GF90Z Graphite Furnaces. Data was expressed as µg/dl. The level of ZPP was measured using the Aviv Biomedical hematofluorometer model 206. Results were expressed in µg ZPP per a gram of hemoglobin (µg/g Hb).
Lipid peroxidation was measured fluorometrically as 2-thiobarbituric acid-reactive substance (TBARS) in serum by Ohkawa (12) . To improve the specificity of the method for MDA, we used sodium sulfate and butylated hydroxytoluene (BHT). TBARS values were expressed as malondialdehyde (MDA) equivalents. Tetraethoxypropane was used as the standard. Results were showed as μmol/l. The level of plasma Hcy was measured by enzyme-linked immunosorbent assay, using a kit by Axis-Shield diagnostics (UK) according to the manufacturer's instructions. Results were expressed as µmol/l.
The serum level of thiol groups was indicated by the method of Koster et al. (13) and displayed as µmoles per gram of protein (µmol/g P). The amount of protein in the serum was measured by the buret method. The method of Oyanagui (14) was used to measure the activity of SOD in serum. In this method, xanthine oxidase produces superoxide anions which react with hydroxylamine forming nitric ions. The ions react with naphthalene diamine and sulfanilic acid generating a colored product. Concentration of this product is proportional to the amount of produced superoxide anions and negatively proportional to the activity of SOD. Absorbance was measured using Shimadzu UV-1700 spectrophotometer at wavelength of 550 nm. The activity of EC-SOD was measured using KCN as the inhibitor of this isoenzyme. The enzymatic activity of SOD was expressed in nitric units. The activity of SOD is equal to 1 nitric unit (NU) when it inhibits nitric ion production by 50%. Activities of SOD were expressed as NU/ml. The concentrations of Cu and Zn in plasma were determined by atomic absorption spectrophotometer using an acetylene-air flame. The results were reported in µg/dl.
Statistical analysis
Statistical analysis was performed using Statistica 9.1 PL software. Statistical methods included the mean and standard deviation. Shapiro-Wilk's test was used to verify normality, whereas Levene's test was used to verify the homogeneity of variances. Statistical comparisons between groups were made by Student's t-test, a t-test with separate variance estimates, or a Mann-Whitney U test. Differences (∆) between the baseline and post-treatment values were determined for all subjects who had β-carotene administered and for subjects in the reference group. Then, differences (∆) in the reference group were compared with the differences (∆) in the group supplemented with β-carotene. Besides, in both groups, the mean and SD of the differences (∆) were calculated. Thus, comparisons between the supplemented group and the reference group were made irrespective of different starting points at the baseline. Dependent variables were analyzed using Student's t-test and Wilcoxon's test. An α value of p < 0.05 was considered to be statistically significant.
RESULTS
At the beginning, the study consisted of 50 participants in the reference group and 35 participants in the CAR group. We further excluded 3 participants who had not been taking β-carotene according to the study protocol. This left 49 subjects in the reference group and 33 subjects in the CAR group. Any significant differences in age, years of work, body mass index (BMI) or smoking habits between the examined groups (Table 1) were not observed. Similarly, there were no differences in PbB and ZPP levels measured before supplementation. At the end of the study, the PbB level decreased significantly in the CAR group compared to baseline and to the reference group. However, supplementation with β-carotene did not affect ZPP levels ( Table 1) . β-carotene administration in lead-exposure Nr 3 313
After supplementation, the level of serum MDA significantly decreased compared to the baseline and to the reference group. A strong tendency toward lower values was observed in the case of Hcy level compared to the baseline. However, when compared to the reference group, Hcy level was significantly decreased ( Table 2) .
The level of thiol groups was significantly higher after supplementation with β-carotene compared to the reference group. Analogically, the activity of SOD and EC-SOD in serum was significantly higher compared to the baseline and to the reference group. The levels of Cu and Zn were not significantly changed after β-carotene administration (Table 2 and 3) .
DISCUSSION
Homocysteine is a thiol-containing amino acid synthesized from methionine via demethylation (15) . In the human body, Hcy impairs the function of vascular endothelial smooth muscle cells through the inhibition of nitric oxide synthesis, increased oxidative stress, proliferation of vascular smooth muscle cells and altered elasticity of the vascular wall. There are 2 pathways of Hcy metabolism. It can be remethylated or undergo transsulfuration to cysteine (16) . In the transsulfuration pathway, the condensation of Hcy and serine to intermediate cystathionine is catalyzed by the enzyme cystathionine β-synthase, which is a pyridoxal 5'-phosphate-dependent heme-containing enzyme. However, in the remethylation pathway, Hcy is remethylated to methionine through the enzyme methionine synthase with vitamin B 12 , folate, and 5,10-methylenetetrahydrofolate reductase (MTHFR).
Because lead disrupts heme biosynthesis, suppressed activity of cystathionine β-synthase could be one mechanism that explains the observed association between blood lead and Hcy. At the same time, the variant enzyme MTHFR might cause lead to bind more to its Table 3 . The activities of superoxide dismutase (SOD) and EC-SOD isoenzyme in serum and the concentration of copper (Cu) and zinc (Zn) in plasma in Pb-exposed population before and after 3 months of supplementation with β-carotene (the CAR group) and observation in the reference group Tabela 3. Aktywność dysmutazy ponadtlenkowej (SOD), jej izoenzymu EC-SOD w surowicy, stężenie miedzi (Cu) i cynku (Zn) w osoczu w grupie porównawczej oraz przed podawaniem i po 3-miesięcznym podawaniu β-karotenu grupie badanej (CAR) active sites. In consequence, lead-induced impairment of the MTHFR function may be the second explanation for the relationship between elevated Hcy and lead levels. Besides, lead may bind to the thiol group of Hcy and hereby inhibit its metabolism. The interactions of lead with folate, vitamin B 6 , and vitamin B 12 are also possible. To sum up, there are many possible mechanisms underlying elevated Hcy level in lead exposure that was reported in several studies (8, 16) . After having controlled for age, sex, race/ethnicity, alcohol intake, cigarette smoking, educational level and BMI, Schafer et al. (16) showed a linear association between blood lead and Hcy in older adults (Baltimore Memory Study). Similarly, in a study by Chia et al. (7), a significant association between blood lead and Hcy among factory workers in a Vietnamese population was detected after controlling for age and gender. Krieg et al. (17) and Yakub and Iqbal (18) showed analogous associations in adult U.S. and Pakistani civilians, respectively.
The present study indicates that supplementation with β-carotene decreases Hcy level in workers exposed to lead. At the beginning of the study, the mean Hcy levels were rather close to the normal level of 15 umol/l in both examined groups. In workers who were then given β-carotene, Hcy decreased to the normal values after 12 weeks of supplementation. At the same time, hyperhomocysteinemia in the reference group was still noted. To our best knowledge, there is no study in the available literature on the influence of β-carotene supplementation on Hcy level when administered separately. Some authors investigated the effect of β-carotenerich tomato juice, a mix of vegetables and fruits as well as fruit and vegetable juice concentrates on the blood levels of cardiovascular disease risk indicators, including Hcy (19) (20) (21) . Due to different study protocols and interactions between administered antioxidants, the obtained results are inconsistent and difficult to interpret. Therefore, further investigations are necessary to explain how β-carotene influences Hcy level.
Antioxidant properties of β-carotene are better documented. However, there have only been few studies on the effect of β-carotene administration on the oxidative stress level in lead-exposure. In these studies, β-carotene was administered together with other antioxidants. In a study by Shastri et al. (22) , a blue-green algae Spirulina fusiformis in a dose of 800 mg/kg body weight, containing β-carotene and SOD, enhanced the survival time in lead-exposed mice. In another study (23) , β-carotene was administered concomitantly with vitamins and microelements for 4 weeks in lead-exposed workers. This intervention increased total antioxidant capacity (TAC) and modified activities of antioxidant enzymes.
The most widely used test for oxidative stress is the measurement of MDA, a product of lipid peroxidation (24) . In the present study, we observed that therapy with β-carotene significantly decreased serum MDA level. These findings are probably due to the ability of β-carotene to react with lipid peroxyl radicals. This reaction theoretically may lead to the β-carotene depletion when its sources in a diet are inadequate. Consistently, Chlebda et al. (25) reported decreased levels of β carotene by 29% in workers exposed to lead (PbB = 35 µg/dl) compared to the unexposed control group (PbB = 5.2 µg/dl).
The level of thiol groups is the 2nd measured parameter indirectly reflects oxidative stress intensity. In our previous study, we reported significantly decreased thiol groups level in a similar group of workers who were exposed to lead (26) . Results of the present study indicate that β-carotene is efficient to restore the level of thiol groups. Therefore, basing on the obtained concentrations of MDA and thiol groups, it is possible to state that β-carotene is able to reduce oxidative stress when administered in lead-exposed workers. This reduction might be also caused by a significant decrease in the PbB level that was reported in the present study after β-carotene administration. Although, there is no evidence that β-carotene has chelating properties. Further investigations should be performed to explain such results.
According to several authors, antioxidant properties of β-carotene are controversial. For example, when β-carotene was administered in smokers, 18%-increase in lung cancer incidence and increased mortality were reported (The Alpha-Tocopherol Beta-Carotene Cancer Prevention Study Group, 1994). Analogous results were shown after the supplementation of patients occupationally exposed to asbestos. Additively, increased frequency of intracerebral haemorrhage cases was noted in supplemented alcoholics (9) .
Data indicates that beneficial antioxidant properties of β-carotene are manifested under low partial pressure of oxygen, while under high oxygen partial pressure the role of antioxidant is rather played by vitamin E. This vitamin is also essential to protect β-carotene from conversion to a toxic peroxyl radical. At the same time, vitamin C reconverts β carotene radical to its parent form. Therefore, under certain conditions, e.g., when there is a vitamin E or C deficiency, β-carotene could act as a pro-oxidant. This biphasic response of β-carotene explains the contradictory results of researches (9,27-29).
β-carotene administration in lead-exposure Nr 3 315 Lead-exposure induces expression and activity of SOD probably as a result of compensatory defense mechanisms against oxidative stress (30) . After β-carotene administration, we observed a significant increase in serum SOD and EC-SOD activity compared to the baseline and to the reference group. Simultaneously, the levels of Cu and Zn remained unaltered after supplementation. Therefore, the reported increase of EC-SOD activity was probably not due to the interactions of lead with metal cofactors of the enzyme. Because products of lipid peroxidation could inactivate superoxide dismutase gene (Sod) by crosslinking or damaging DNA (31) , elevated SOD activity may be rather a result of decreased lipid peroxidation by β-carotene.
CONCLUSIONS
Beta-carotene in a dose of 10 mg a day administered orally to workers chronically exposed to lead decreased the level of atherogenic homocysteine and reduced oxidative stress measured as malondialdehyde level. Besides, the medication was well-tolerated with no evidence of adverse side effects.
Concluding, despite some controversies over antioxidant properties of β-carotene, our results indicate that its antioxidant action could provide some beneficial effects in lead-exposure independent of chelation.
